RECRUITING

Association of Near Infrared Spectroscopy With Interstage Outcomes

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assess the utility of renal near infrared spectroscopy in the outpatient setting during the interstage period. The primary aim will be to determine the correlation between oxygen extraction ratio ((arterial pulse oximetry - renal near infrared spectroscopy value)/arterial pulse oximetry value) with need for inpatient admission or intervention. Secondary aims will be to determine the correlation of the oxygen extraction ratio with weight gain, neurodevelopment, unexpected admissions, systemic ventricular strain by echocardiography, and Glenn hospitalization admission characteristics.

Official Title

Association of Renal Near Infrared Spectroscopy in Outpatients With Parallel Circulation During the Interstage Period and Interstage Morbidity

Quick Facts

Study Start:2024-07-01
Study Completion:2026-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06538571

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified to 6 Months
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Infants under 6 months of age
  2. * Infants with single ventricle heart disease and parallel circulation
  3. * Infants who are awaiting the Glenn operation
  4. * Infants who are outpatient
  1. * Infants over 6 months of age
  2. * Inpatients
  3. * Infants with history of skin injury from the near infrared spectroscopy sensor inpatient
  4. * Infants with ongoing hyperbilirubinemia

Contacts and Locations

Study Contact

JOSHUA WONG, MD
CONTACT
708-684-5580
joshua.wong@aah.org

Principal Investigator

Joshua Wong, MD
PRINCIPAL_INVESTIGATOR
Advocate Children's Hospital

Study Locations (Sites)

Advocate Childrens Hospital
Oak Lawn, Illinois, 60453
United States

Collaborators and Investigators

Sponsor: Advocate Hospital System

  • Joshua Wong, MD, PRINCIPAL_INVESTIGATOR, Advocate Children's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-01
Study Completion Date2026-07-01

Study Record Updates

Study Start Date2024-07-01
Study Completion Date2026-07-01

Terms related to this study

Additional Relevant MeSH Terms

  • Single-ventricle